[{"Assets_0_Q2_USD":311564573.0,"NetCashProvidedByUsedInOperatingActivities_2_Q2_USD":48968.0,"NetIncomeLoss_2_Q2_USD":521197.0,"NetIncomeLoss_1_Q2_USD":380334.0,"StockholdersEquity_0_Q2_USD":5000008.0,"Ticker":"ORGO","CIK":"1661181","name":"AVISTA HEALTHCARE PUBLIC ACQUISITION CORP.","OfficialName":"Organogenesis Holdings Inc. Class A Common Stock","form":"10-Q","period":"20170630","fy":"2017.0","fp":"Q2","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"968314582.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20170811"}]